Stago webinar: Emerging biomarker for thrombotic risk stratification in coronary artery disease
Clinicians, clinical pathologists, researchers, and clinical laboratory staff will have the opportunity to deepen their knowledge of the role of TF-positive platelets in arterial thrombosis and CAD progression, as well as their potential to improve thrombotic risk stratification beyond traditional models.
Read more
Stago enters into exclusive negotiations with ARCHIMED and La Caisse
PRESS RELEASE: December 11, 2025
The Stago Group, a global leader in diagnostics and a specialist in hemostasis, announced today that it has entered into exclusive negotiations with a consortium led by ARCHIMED, an investment fund dedicated to the healthcare sector, with a view to acquiring a majority stake in the group. La Caisse (formerly Caisse de dépôt et Placement du Québec) would invest alongside ARCHIMED as a minority investor.
Read more
Stago's 2025 CSR Report is online
The Stago Group’s commitment to sustainability takes a new step forward with the release of our latest CSR report. More comprehensive, concrete, and forward-looking, it reflects the collective efforts of our international teams and subsidiaries, and the growing integration of CSR into our daily actions and long-term vision.
Read more
New Focus on Extracellular Vesicles
This Focus leaflet illustrates how extracellular vesicles (EVs), once confined to basic research, are now on the path to becoming valuable tools in clinical diagnostics. This last issue has been coordinated by Professor Françoise Dignat-George, recipient of the ISTH Esteemed Career Award 2025.
Read more
New Practical Manual on Hemostasis and Thrombosis in special patient populations
This new book is dedicated to the challenges of hemostasis and thrombosis in special patient populations, offering practical guidance for interpreting test results and improving patient care.
Read more
